WebWorld Development Indicators (WDI) is the primary World Bank collection of development indicators, compiled from officially recognized international sources. It presents the most current and accurate global development data available, and includes national, regional and global estimates. [Note: Even though Global Development … WebThis is the second Development Safety Update Report (DSUR) for Vasculogenesis Growth Factor-2 (VGF-2), covering the period from April 17, 2010 to April 16, 2011. Our IND went into effect on April 17, 2009, and this is the Development International Birth Date. VGF-2 is a biotechnology-derived product, an arteriogenic, heparin-binding 37-kD
プレゼンスライド1 DSURの意義 Web公開用 - JPMA
WebJan 1, 2024 · The development International Birth Date, i.e., date of first approval of conduct of a clinical trial in any country, is used to determine the start of the annual period for the DSUR. The DSUR should be submitted no later than 60 calendar days from the DSUR data lock point. A single DSUR should be prepared in case of clinical trials on … WebNov 28, 2024 · DSUR data lock point (DIBD) can coincide with the International Birth Date (IBD) if desired by sponsor. Recipients of DSUR. Regulatory Authorities: DSUR; within 60 days from the DIBD; EC/IRB, if required: Executive Summary (plus line listing of SADRs) Final DSUR in a Territory: will be notified with a cover letter. DSUR Contents. Title page lowhd
Guideline on good pharmacovigilance practices (GVP)
WebInternational Birth Date. A date of the first Marketing Authorisation of a medicinal product granted to the Marketing Authorisation Holder (MAH) in any country worldwide. Look up a Glossary Term. WebAug 17, 2024 · Taking into consideration the safety data from the new reporting period and the cumulative data recorded from the Development International Birth Date the sponsor should provide an interpretation of the information and its implications in terms of risk mitigation strategies (ICH E2F, 3.18). Websince the Developmental International Birth Date of the drug. The line listings and tabulations should include blinded and unblinded clinical trial data. Unblinded data might originate from completed trials and individual cases that have been unblinded for safety reasons (e.g., expedited reporting), if applicable. Data should not be jarrell tree service covington louisiana